2026 Return to the Festival of Genomics
Why We’re Excited to Return to the Festival of Genomics We’re really pleased to be returning to the Festival of Genomics & Biodata Science in London this year. Last year’s Festival stood out for us not just because of the scale or the quality of the programme, but because of the conversations we […]
Welcome to XetaBase Version 4
XetaBase Version 4 marks one of the most significant upgrades to the platform to date, bringing major improvements in clinical efficiency, usability, and large-scale genomic performance. Designed closely with feedback from clinicians, researchers, and informatics teams, V4 introduces a faster, cleaner interface, enriched clinical tooling, automated workflows, and a performance-optimised architecture that scales effortlessly. […]
Clinical Improvements in XetaBase Version 4: Driving Clinical Precision Through User-Led Innovation in XetaBase
User feedback has been the backbone of our clinical evolution at XetaBase. Over the past year, we have worked closely with clinicians, bioinformaticians, and diagnostic laboratory teams to understand where genomic analysis platforms must do more: reduce friction, accelerate turnaround times, and provide richer context at the point of decision. This dialogue has directly shaped […]
Zetta Genomics to Join the PMFG Sidra Conference, 2-4 December, Doha
Zetta Genomics is pleased to announce our participation in the PMFG Sidra Conference next week, a key gathering for the leaders shaping the next decade of genomics, precision medicine, and data-driven healthcare. Representing Zetta Genomics at the event will be our Chief Commercial Officer, Mark Hughes, who will also be chairing a session during the […]
Event: AWS Genetic Research Conference 2025, London November 2025
Zetta has been reflecting on our time at Amazon Web Services (AWS)‘s GenResCon, which brought together an exceptional group of leaders from across the UK genomics and health data landscape. Hearing from speakers spanning UK Biobank, Genomics England, National Disease Registration Service, NIHR BioResource, Health Data Research UK (HDR UK), Our Future Health UK, the […]
Variant Stores: Why You Need A Variant Store And What Makes It Truly Useful
In the era of precision medicine, genomics has become one of the most valuable datasets in healthcare and life sciences. Yet, despite its promise, genomic data is notoriously difficult to manage. With sequencing pipelines producing terabytes of raw data daily, the challenge is no longer generating information, it’s understanding it. That’s where variant stores come […]
Xeta Variant Annotation Store: Why You May Need One And What Makes It Truly Useful
Zetta Genomics offers a SaaS-based Variant Annotation Store on AWS Marketplace, so let’s discuss why it’s key to your genomic analysis. From Raw Data to Real Discovery Modern genomics has moved beyond data generation. Sequencing technology has given researchers the power to decode entire genomes at scale, but raw data alone doesn’t create insight. The […]
Zetta’s SaaS Products Are Available On AWS As Healthomics Closes Its Variant Store And Annotation Stores To New Customers
Zetta Genomics have launched their SaaS-based Annotation and Variant Stores products on AWS as an alternative to AWS HealthOmics products. AWS announced that, starting November 7, 2025, it will no longer accept new customers for its Variant Stores and Annotation Stores, though existing customers can continue to use these services as usual. What […]
Zetta Genomics Shortlisted for Two UK Tech Awards
We are proud to announce that Zetta Genomics has been shortlisted for not one, but two categories at the prestigious UK Tech Awards 2025: Tech for Good Innovation of the Year These nominations are a recognition of the incredible progress we are making in applying cutting-edge technology to one of the most urgent challenges of […]
New Genetic Insights Reveal Lung Cancer Risk Factors in African Ancestry Populations
Researchers from Vanderbilt University Medical Center, the National Cancer Institute, and other U.S. centers have uncovered previously underappreciated genetic contributors to lung cancer risk among individuals of African ancestry, who experience disproportionately high rates of the disease and often face more aggressive forms at diagnosis. The findings, published in the American Journal of Human Genetics, […]
